Columbus McKinnon Corp
NASDAQ:CMCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Columbus McKinnon Corp
NASDAQ:CMCO
|
US |
|
Brightspire Capital Inc
NYSE:BRSP
|
US |
|
ImmuPharma PLC
LSE:IMM
|
UK |
|
PostNL NV
AEX:PNL
|
NL |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
JP |
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
W
|
Willow Biosciences Inc
OTC:CANSF
|
CA |
|
E
|
Eiffage SA
XBER:EF3
|
FR |
|
I
|
Infineon Technologies AG
MIL:IFX
|
DE |
|
Spirit AeroSystems Holdings Inc
NYSE:SPR
|
US |
|
Core Scientific Inc
NASDAQ:CORZ
|
US |
|
H
|
Hochtief AG
SWB:HOT
|
DE |
|
Shimano Inc
OTC:SHMDF
|
JP |
|
T
|
Thomson Reuters Corp
F:TOCB
|
CA |
|
Embotelladora Andina SA
NYSE:AKO.B
|
CL |
|
I
|
Itron Inc
F:IT6
|
US |
|
Isik Plastik Sanayi ve Dis Ticaret Pazarlama AS
IST:ISKPL.E
|
TR |
|
Medical Data Vision Co Ltd
TSE:3902
|
JP |
|
T
|
Tempur Sealy International Inc
NYSE:SGI
|
US |
|
TotalEnergies EP Gabon
PAR:EC
|
GA |
|
Spic Yuanda Environmental Protection Co Ltd
SSE:600292
|
CN |
|
Insmed Inc
NASDAQ:INSM
|
US |
|
APL Apollo Tubes Ltd
NSE:APLAPOLLO
|
IN |
|
B3 Consulting Group AB (publ)
STO:B3
|
SE |
Wall St Price Targets
CMCO Price Targets Summary
Columbus McKinnon Corp
According to Wall Street analysts, the average 1-year price target for CMCO is 26.86 USD with a low forecast of 20.2 USD and a high forecast of 31.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CMCO's stock price target?
Price Target
26.86
USD
According to Wall Street analysts, the average 1-year price target for CMCO is 26.86 USD with a low forecast of 20.2 USD and a high forecast of 31.5 USD.
What is the Revenue forecast for Columbus McKinnon Corp?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 32%.
What is the Operating Income forecast for Columbus McKinnon Corp?
Projected CAGR
52%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 52%.
